Table 1 Patient characteristics
| Â | patient with AF | patients without AF | Â | Â | ||||
|---|---|---|---|---|---|---|---|---|
variable | persistent AF n = 14, paroxysmal AF n = 6 | future onset AF (1y after surgery) n = 15 | non-AF, 1 year after surgery n = 20 | p value: AF vs without AF | p value: future onset vs non-AF | |||
Surgery type n (%) | Thoracos-copic AF ablation | 20 (100) | CABG/AVR | 14 (93), 1 (7) | CABG/AVR | 18 (90), 2 (10) | N/A | Â |
Male sex n (%) | 19 | (95.0) | 12 | (80) | 17 | (85) | 0.30 | 0.6 |
Age [IQR] | 59.5 | [10.4] | 73.6 | [16.3] | 69.1 | [8.2] |  < 0.01 | 0.4 |
BMI (± SD) | 29.0 | (3.4) | 27.5 | (3.6) | 27.3 | (3.0) | 0.09 | 0.8 |
LAVI % [IQR] | 41.9 | [14.7] | 30.3 | [15] | 25.8 | [11] |  < 0.01 | 0.9 |
CHA2DS2-VASc [IQR] | 1 | [2] | 3 | [2] | 3 | [1] |  < 0.01 | 0.5 |
Hypertension n (%) | 9 | (45) | 9 | (60) | 11 | (55) | 0.42 | 1.0 |
Diabetes n (%) | 3 | (15) | 5 | (30) | 10 | (50) | 0.04 | 0.3 |
Vascular disease n (%) | 3 | (15) | 13 | (87) | 19 | (95) |  < 0.01 | 0.6 |
Stroke n (%) | 2 | (10) | 1 | (7) | 3 | (15) | 1 | 1.0 |
Congestive heartfailure n (%) | 1 | (5) | 0 | 0 | 0 | 0 | 0.30 | 1.0 |
CRP [IQR] | 1.4 | [2.4] | 1.8 | [2.9] | 1.4 | [5] | 0.45 | 0.6 |
Leukocytes, 10–9/L (± SD) | 6.5 | (1.4) | 7.6 | (1.5) | 7.6 | (2.1) | 0.02 | 1.0 |
Thrombocytes, 10–9/L (± SD) | 252.4 | (39.5) | 222 | (53.1) | 242 | (41.5) | 0.14 | 0.5 |
OAC n (%) | 20 | (100) | 0 | (0) | 0 | (0) |  < 0.01 | 1.0 |
Antiplatelets n (%) | 0 | (0) | 14 | (93) | 19 | (95) |  < 0.01 | 1.0 |
Statins n (%) | 2 | (10) | 10 | (66) | 19 | (95) |  < 0.01 | 0.1 |